Tumour necrosis factor receptor (TNFR)1 is the main receptor responsible for TNF-induced diverse cellular events. In this study, we report that TNFR1 has a crucial role in endoplasmic reticulum (ER) stress-induced Jun amino-terminal kinase (JNK) activation. Although ER stress leads to JNK activation in wild-type mouse embryo fibroblasts, we failed to detect any JNK activation in TNFR1À/À cells. ER stress-induced JNK activation is restored in TNFR1À/À cells when TNFR1 expression is reconstituted. We also found that TNFR1 functions downstream of IRE1 and that IRE1 is present in the same complex with TNFR1 under ER stress condition. Therefore, our study shows a novel role of TNFR1 in mediating ER stress-induced JNK activation.
INTRODUCTION
Tumour necrosis factor receptor (TNFR)1 is the main receptor that mediates many TNF-induced cellular events such as septic shock, induction of cytokines, cell proliferation, differentiation and apoptosis (Tracey & Cerami, 1993; Baud & Karin, 2001) . In response to TNF treatment, TNFR1 trimerizes and forms a signalling complex with several adaptor proteins, including TNF receptor-associating factor 2 (TRAF2) and TNF receptorinteracting protein (RIP), and elicits diverse cellular responses. It has been shown that TRAF2 and RIP are essential signalling components of TNF-induced activation of the transcription factor nuclear factor-kB (NF-kB) and of mitogen-activated protein (MAP) kinases (Liu et al, 1996; Reinhard et al, 1997; Chen & Goeddel, 2002; Devin et al, 2003) . Although TRAF2 was first identified as a protein that interacts with TNFR2, it was subsequently found in the receptor complex of several other TNFR family members, such as CD40, CD30 and TNFR1 (Rothe et al, 1994; Arch et al, 1998; Wajant & Scheurich, 2001) . TRAF2 is one of the seven known TRAF family members. All the members of this family have a conserved carboxy-terminal domain, known as the TRAF domain, which mediates receptor/adaptor binding as well as homo-and hetero-oligomerization with other TRAF proteins (Bradley & Pober, 2001; Chung et al, 2002) . RIP is a death domain kinase first identified as a Fas (CD95)-interacting protein (Stanger et al, 1995) . Later studies showed its crucial role in TNF and TRAIL (TNF-related apoptosis-inducing ligand) signalling Lin et al, 2000) . Although they are known as the key effector proteins of TNF signalling, TRAF2 and RIP are also involved in other cellular responses under diverse stress conditions, including oxidative stress and DNA damage (Hur et al, 2003; Shen et al, 2004; Noguchi et al, 2005) .
The endoplasmic reticulum (ER) is the organelle in which protein folding occurs and the accumulation of unfolded proteins in the lumen of the ER results in induction of the unfolded protein response (UPR) and in activation of the MAP kinase Jun amino-terminal kinase (JNK; Urano et al, 2000) . In response to ER stress, caused by glucose starvation, disturbance of intracellular stores of Ca 2þ stores or inhibition of protein glycosylation, protein folding reactions are compromised and malfolded proteins accumulate in the ER lumen. To maintain cellular homeostasis, the stressed cells induce an adaptive response, the so-called UPR (Mori, 2000; Ma & Hendershot, 2001; Patil & Walter, 2001 ). The UPR is of fundamental importance for the survival of all eukaryotic cells under the condition of ER stress and normal growth conditions. Alteration of the ER processing of unfolded proteins by pathogens or genetic lesions results in disease (Aridor & Balch, 1999) . In mammals, the UPR is mediated by three types of ER transmembrane protein: the protein kinase and site-specific endoribonuclease IRE1 (Tirasophon et al, 1998; Wang et al, 1998; Iwawaki et al, 2001) ; the eukaryotic translation initiation factor 2 kinase PERK/PEK (protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase; Shi et al, 1998; Harding et al, 1999 Harding et al, , 2000 ; and the transcriptional activator ATF6 (Yoshida et al, 1998 (Yoshida et al, , 2001 Li et al, 2000) . It has also been reported that MAP kinase JNK is activated under ER stress condition and that IRE1 has a crucial role in this process by recruiting TRAF2 (Urano et al, 2000) .
In this report, we show that TNFR1 mediates ER stress-induced JNK activation independently of TNF. By using RIPÀ/À and TNFR1À/À fibroblasts, we found that RIP and TNFR1 are required for JNK activation in response to ER stress. ER stress induces JNK activation in wild-type (WT) but not RIPÀ/À or TNFR1À/À fibroblasts. Ectopic expression of RIP or TNFR1 in RIPÀ/À or TNFR1À/À fibroblasts restored ER stress-induced JNK activation. Overexpression of IRE1a failed to activate JNK in TNFR1À/À cells. Our co-immunoprecipitation experiments indicated that TNFR1 might interact with IRE1a and that IRE1a might be present in the same complex with TNFR1 and RIP following ER stress. Therefore, our study shows that TNFR1 is the crucial mediator of ER stress-induced JNK activation.
RESULTS AND DISCUSSION JNK activation by ER stress requires RIP and TNFR1
It has been suggested that IRE1a mediates ER stress-induced JNK activation by recruiting TRAF2 (Urano et al, 2000) . As we found that RIP is also required for TNF-induced JNK activation, we tested whether RIP is involved in ER stress-induced JNK activation. As shown in Fig 1A, when WT fibroblasts were treated with thapsigargin (Tg) or tunicamycin (Tu), which induce ER stress by the depletion of ER Ca 2þ stores or inhibition of protein glycosylation, respectively, JNK activity, measured by in vitro kinase assay (Liu et al, 1996) , is elevated. However, we failed to detect any JNK activation after Tg or Tu treatment in RIPÀ/À fibroblasts ( Fig 1A) . The protein levels of JNK1 and RIP in WT and RIPÀ/À cells were detected with an anti-JNK1 or an anti-RIP antibody, as shown in Fig 1A. This observation was further confirmed with anti-phospho-JNK antibody (Fig 2C) . To prove that the lack of JNK activation in RIPÀ/À cells is due to the absence of RIP protein, we established RIPÀ/À cells that were stably transfected with RIP ( Fig 1B) . As shown in Fig 1C, ER stressinduced JNK activation was recovered in RIP-reconstituted RIPÀ/À cells, even though the protein level of RIP was much lower in RIP-reconstituted cells than in WT cells (Fig 1B) . These results indicate that RIP, like TRAF2, is essential for JNK activation in response to ER stress.
As both TRAF2 and RIP are key effector molecules for TNF signalling, we examined whether TNFR1 is involved in ER stressinduced JNK activation. To do so, WT and TNFR1À/À fibroblast cells (Fig 2A) were treated with Tg or Tu. As shown in Fig 2B, JNK activation was detected at 30 min after Tg treatment, it peaked at 1 h and was still detectable at 2 h in WT fibroblast cells. In contrast, no obvious JNK activation was detected in response to Tg in TNFR1À/À fibroblast cells. This observation is further confirmed by anti-phospho-JNK antibody (Fig 2C) . Similarly, Tuinduced JNK activation was found only in WT cells but not in TNFR1À/À cells ( Fig 2D) . As controls, TNF-and UV-induced JNK activation was also examined in these cells. Whereas UV treatment led to robust JNK activation in both WT and TNFR1À/À cells, TNF activates JNK only in WT and not in TNFR1À/À cells. These results indicated that TNFR1 is required for ER stress-induced JNK activation. To test whether ectopic expression of TNFR1 in TNFR1À/À cells could restore ER stress-induced JNK activation, we transiently transfected a plasmid encoding Flag-tagged TNFR1 into TNFR1À/À cells. As shown in Fig 2E , JNK activation by Tg was reconstituted when Flag-TNFR1 was presented in TNFR1À/À cells. Haemagglutinin (HA)-JNK and TNFR1 protein levels in these experiments are shown in Fig 2E as controls. Therefore, these findings indicate that, in addition to TRAF2 and RIP, TNFR1 might be essential for ER stress-induced JNK activation.
IRE1a interacts with TNFR1 following ER stress
As both TNFR1 and TNFR2 are able to mediate TNF signalling, we tested whether TNFR2 is required for ER stress-induced JNK activation. As shown in Fig 3A, whereas Tg treatment failed to elevate JNK activity in TNFR1À/À cells, JNK activation by Tg was relatively normal in TNFR2 fibroblast cells. These results indicate that ER stress-induced JNK activation is specifically mediated by TNFR1. Because TRAF2 and RIP, two key effector molecules of TNFR1 signalling, are also involved in ER stress-induced JNK activation, these data indicate that ER stress engages the TNFR1 pathway to activate JNK. One possibility is that ER stress may result in the production or release of TNF, which then activates TNFR1 signalling, leading to JNK activation. To explore this possibility, an antagonistic TNFR1 antibody was used to block TNFR1 signalling. For this, WT fibroblast cells were incubated with this antibody 30 min before Tg or TNF treatment. As shown in Fig 3B , the administration of this TNFR1 antibody completely blocked TNF-induced JNK activation but had little effect on Tg-induced JNK activation. Therefore, it is unlikely that ER stress-induced JNK activation is due to the production or release of TNF in cells under ER stress. Role of TNFR1 in ER stress-induced JNK activation Q. Yang et al
It has been reported that overexpression of IRE1a leads to the activation of JNK. To help understand the mechanism by which TNFR1 mediates ER stress-induced JNK activation, we tested whether JNK activation by IRE1a overexpression requires TNFR1. For this, we co-transfected HA-JNK1 and Flag-IRE1a plasmids into WT and TNFR1À/À fibroblast cells, and JNK activity was measured by an in vitro kinase assay after immunoprecipitation of HA-JNK1. As shown in Fig 4A, overexpression of IRE1a activates JNK in WT fibroblast cells, but not in TNFR1À/À cells. These results indicate that TNFR1 may function downstream of IRE1a in the process of JNK activation in response to ER stress. The early study by Urano et al (2000) showed that IRE1a mediates ER stress-induced JNK activation by interacting with TRAF2. As our data indicate that TNFR1 is downstream of IRE1a, we tested whether IRE1a interacts with TNFR1. We co-transfected 293 cells with Flag-IRE1a and green fluorescent protein (GFP)-TNFR1 plasmids and carried out immunoprecipitation experiments with anti-GFP antibody. As shown in Fig 4B, Flag-tagged IRE1a was co-immunoprecipitated with GFP-TNFR1 and the treatment of Tg increased the interaction between IRE1a and TNFR1. As it is known that IRE1a interacts with TRAF2 and that TRAF2 is a key effector of TNFR1 signalling, we performed similar co-immunoprecipitation experiments in TRAF2À/À fibroblast cells to rule out the possibility that the interaction between IRE1a and TNFR1 is mediated by TRAF2, and similar results to those in Fig 4B were obtained with TRAF2À/À cells (data not shown). These results indicate that IRE1a interacts with TNFR1 independently of TRAF2. As TNFR1 normally localizes within cell plasma membrane, whereas IRE1a is at ER, it is important to know whether TNFR1 localizes at ER after ER stress. To investigate this possibility, we stained WT MEF cells with anti-TNFR1 antibody and anti-calnexin (CNX), which specifically labels ER. As shown in Fig 4C, there is a small amount of TNFR1 localized at ER before Tg treatment. But the level of TNFR1 at ER is markedly increased after Tg treatment. Therefore, these results imply that TNFR1 accumulates in ER under ER stress condition. As a control, we used the same anti-TNFR1 antibody to stain TNFR1À/À cells and did not observe any specific staining (data not shown). Finally, we examined whether endogenous IRE1a and TNFR1 form a complex in response to ER stress. As shown in Fig 4D, after Tg treatment, WT fibroblast cells were collected at different periods of time and immunoprecipitation experiments were carried out with an anti-TNFR1 antibody. Both RIP and IRE1a were coprecipitated with TNFR1 in response to Tg treatment, indicating Role of TNFR1 in ER stress-induced JNK activation Q. Yang et al that TNFR1, IRE1a and RIP might form a complex in cells under ER stress. Previous studies have suggested that JNK activation is crucial for ER-induced apoptosis (Nishitoh et al, 2002; Nawrocki et al, 2005) . As we found that TNFR1 and RIP are required for ER stressinduced JNK activation, we next tested whether TNFR1 and RIP are involved in ER stress-induced apoptosis. As shown in supplementary Fig 1 online , both TNFR1-and RIP-null MEFs are more resistant than WT MEF cells to ER stress-induced apoptosis. We also examined Bip/GRP78 expression and XBP1 protein in TNFR1À/À cells after Tg treatment. Bip/GRP78 messenger RNA level and the level of the spliced form of XBP1 protein are decreased in TNFR1À/À cells ( supplementary Fig 2 online) . We examined ASK1 activation as well and did not detect any ASK1 activation in WT or TNFR1À/À cells after Tg treatment (data not shown).
TNFR1 is known as the key receptor responsible for eliciting diverse cellular events in response to TNF. Our study shows that TNFR1 is a crucial mediator of ER stress-induced JNK activation. As TNFR1 signalling can activate NF-kB, we also examined whether ER stress leads to the activation of NF-kB, as reported recently (Mauro et al, 2006) . However, we failed to detect any NF-kB activation after Tg or Tu treatment on examining IkBa degradation (data not shown). One possible explanation is that certain modifications, such as ubiquitination, of crucial signalling molecules, which are necessary for activating NF-kB by TNFR1, did not take place when the IRE1a, TNFR1 and RIP complex formed in response to ER stress. This may be true, because we did not find any ubiquitinated RIP in the IRE1a/TNFR1 complex (Fig 4D) .
Earlier reports have suggested that TNF is important in ER stress and that several TRAF proteins including TRAF2 and TRAF7 are crucial mediators of ER stress responses (Urano et al, 2000; Xu et al, 2004; Xue et al, 2005) . However, our current study provided evidence that TNFR1 also has a key role in ER stress-induced JNK activation and apoptosis. More importantly, our work shows a novel function of TNFR1 independently of its ligand, TNF. Our finding that TNFR1, RIP and IRE1a form a complex in response to ER stress implies that IRE1a recruits TNFR1 to form a signalling complex, which in turn leads to JNK activation.
METHODS
Reagents. Tg and Tu were from Sigma (St Louis, MO, USA). Antibodies of TNFR1 and TNFR2 were from R&D Systems (Minneapolis, MN, USA), anti-JNK1 was from Pharmingen (San Jose, CA, USA) and anti-phospho-JNK1 was from Cell Signaling (Beverly, MA, USA). The antibody against RIP was from Transduction Laboratories (San Jose, CA, USA). Anti-HA and anti-GFP were from Santa Cruz (Santa Cruz, CA, USA), and antiactin and anti-Flag were purchased from Sigma. Cell culture. WT, TNFR1À/À, TNFR2À/À and RIPÀ/À mouse 3T3-like fibroblast cells and 293 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (100 U/ml) and streptomycin (100 mg/ml). RIP-reconstituted stable cell lines (RIPÀ/À(RIP)) were also cultured in this medium, including 300 mg/ml hygromycin B. Western blot analysis. After treatment as described in the figure legends, cells were collected and lysed in M2 buffer (20 mM Tris-HCl pH 7.0, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM dithiothreitol, 0.5 mM phenylmethylsulphonyl fluoride, 20 mM glycerol phosphate, 1 mM sodium vanadate, 1 mg/ml leupeptin). The cell lysate (20 mg) from each sample was fractionated by SDS-polyacrylamide gel electrophoresis and immunoblotted. The blots were visualized with enhanced chemiluminescence in accordance with the manufacturer's instructions (Amersham, Piscataway, NJ, USA). Kinase assays. Transfected or non-transfected cells were treated with Tg or Tu as indicated in the figure legends and then collected in M2 lysis buffer. JNK1 was immunoprecipitated with anti-JNK1 or anti-HA antibody and collected with protein A-Sepharose beads (Roche, Penzberg, Germany). JNK kinase activities were determined using GST-c-Jun (1-79) substrates. Immunoprecipitation assay. 293 cells were co-transfected with plasmids GFP-TNFR1 and Flag-IRE1a and then treated with Tg. Non-transfected WT cells were treated as indicated in the figure legend. Then, the cells were collected in M2 lysis buffer. The immunoprecipitation experiments were carried out with anti-GFP antibody or anti-TNFR1 antibody. Proteins were resolved by SDS-polyacrylamide gel electrophoresis and detection was accomplished by western blot. Immunostaining assay. WT MEF cells were double-stained with anti-TNFR1 and ER marker protein CNX antibody. Cells were treated with 2 mM Tg for 30 or 45 min, washed with 1 Â PBS three times and then fixed with 4% paraformaldehyde. After washing Role of TNFR1 in ER stress-induced JNK activation Q. Yang et al
